NABI BIOPHARMACEUTICALS : Biotech Watchlist 2013 Update: Exciting

Profil supprimé

03 mai 2013 •16:53

Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential

TICKERS: AMRN, ALPMF, BAYN, CAH, CLSN, GALE, HPTX, MDVN, NAVB, NVS, ONXX, PPHM, PFE, PCYC, PBT, SGMO, SRPT, TSRX, VRTX

Source: George S. Mack of The Life Sciences Report (5/2/13)

In January 2013, The Life Sciences Report debuted its biotech Watchlist, which outlined ideas for investors keyed to catalysts in the drug development process that typically move biotechnology stocks. All stocks are affected by catalysts, but nowhere do they provide more leverage (or deleverage) than in biotech. We predicted the new year would present legitimate prospects for portfolio growth. So far, that has been the case. Although the party has given way to some fatigue, the punch bowl is still on the table and the biotech upswing continues...

suite:
http://www.thelifesciencesreport.com/pub/na/15211